Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate pilot study in adult men with X-linked adrenoleukodystrophy
NL-OMON32731Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bezafibrate in adrenoleukodystrophy (ALD), sponsored by Amsterdam University Medical Center. Primary endpoints: Plasma cholesterol, Plasma triglycerides and 4 more. Planned start Jan 2010; status: not yet recruiting.
02
Drugs
bezafibrate
03
Conditions
adrenoleukodystrophy (ALD)
Beyond the preview
Go deeper on NL-OMON32731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32731.